Andrea Ibarra1, Kimberly Howard-Quijano1, Gavin Hickey2,3, William Garrard4, Floyd Thoma2, Aman Mahajan1, Arman Kilic2,5. 1. Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. 2. Heart and Vascular Institute, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. 3. Division of Cardiology, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. 4. Division of Cardiac Surgery, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA. 5. Clinical Analytics, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
Abstract
BACKGROUND: Socioeconomic status (SES) can be a powerful predictor of adverse outcomes among heart failure patients but its impact on survival and readmission following left ventricular assist device (LVAD) implantation surgery is poorly understood. We investigated if the LVAD recipients from more deprived neighborhoods experienced higher mortality and readmission rate after device implantation as compared to those from less deprived areas. METHODS: This is a single center, retrospective analysis evaluating adults who received Heartmate III and Heartware HVAD implants between 2009 and 2018. SES indicators were area of deprivation index (ADI), race and income. Our cohort was grouped by ADI quartiles from least deprived (Q1), Q2, Q3 to the most deprived (Q4). Outcomes included overall mortality and readmission following surgery. RESULTS: A total of 191 patients were included in the study. Demographics by SES indicators demonstrated that least deprived (Q1) patients were older than the most deprived (65 vs. 57, p < .01), African-American patients originated from more deprived neighborhoods than Caucasians (ADI 87 vs. 62, p < .001), and high-income patients had higher preoperative BUN and creatinine. Outcome differences included a decreased risk of death in most deprived patients (Q4) compared to the least deprived (Q1), however after adjusting for age, LVAD indication, and INTERMACS profile this was no longer significant. No differences in survival or readmission by race or income was observed CONCLUSION: SES does not independently impact survival and readmission after Heartware HVAD and Heartmate III LVAD implantation. More studies are needed to evaluate if other SES factors affect these outcomes.
BACKGROUND: Socioeconomic status (SES) can be a powerful predictor of adverse outcomes among heart failure patients but its impact on survival and readmission following left ventricular assist device (LVAD) implantation surgery is poorly understood. We investigated if the LVAD recipients from more deprived neighborhoods experienced higher mortality and readmission rate after device implantation as compared to those from less deprived areas. METHODS: This is a single center, retrospective analysis evaluating adults who received Heartmate III and Heartware HVAD implants between 2009 and 2018. SES indicators were area of deprivation index (ADI), race and income. Our cohort was grouped by ADI quartiles from least deprived (Q1), Q2, Q3 to the most deprived (Q4). Outcomes included overall mortality and readmission following surgery. RESULTS: A total of 191 patients were included in the study. Demographics by SES indicators demonstrated that least deprived (Q1) patients were older than the most deprived (65 vs. 57, p < .01), African-American patients originated from more deprived neighborhoods than Caucasians (ADI 87 vs. 62, p < .001), and high-income patients had higher preoperative BUN and creatinine. Outcome differences included a decreased risk of death in most deprived patients (Q4) compared to the least deprived (Q1), however after adjusting for age, LVAD indication, and INTERMACS profile this was no longer significant. No differences in survival or readmission by race or income was observed CONCLUSION: SES does not independently impact survival and readmission after Heartware HVAD and Heartmate III LVAD implantation. More studies are needed to evaluate if other SES factors affect these outcomes.
Authors: Elvis A Akwo; Edmond K Kabagambe; Frank E Harrell; William J Blot; Justin M Bachmann; Thomas J Wang; Deepak K Gupta; Loren Lipworth Journal: Circ Cardiovasc Qual Outcomes Date: 2018-01
Authors: James K Kirklin; Francis D Pagani; Robert L Kormos; Lynne W Stevenson; Elizabeth D Blume; Susan L Myers; Marissa A Miller; J Timothy Baldwin; James B Young; David C Naftel Journal: J Heart Lung Transplant Date: 2017-07-15 Impact factor: 10.247
Authors: Autumn M Clemons; Raul J Flores; Raia Blum; Brian Wayda; Danielle L Brunjes; Marlena Habal; Raymond C Givens; Lauren K Truby; A Reshad Garan; Melana Yuzefpolskaya; Koji Takeda; Hiroo Takayama; Maryjane A Farr; Yoshifumi Naka; Paolo C Colombo; Veli K Topkara Journal: ASAIO J Date: 2020-04 Impact factor: 2.872
Authors: Joseph G Rogers; Keith D Aaronson; Andrew J Boyle; Stuart D Russell; Carmelo A Milano; Francis D Pagani; Brooks S Edwards; Soon Park; Ranjit John; John V Conte; David J Farrar; Mark S Slaughter Journal: J Am Coll Cardiol Date: 2010-04-27 Impact factor: 24.094
Authors: Anuradha Lala; John C Rowland; Bart S Ferket; Annetine C Gelijns; Emilia Bagiella; Sean P Pinney; Alan J Moskowitz; Marissa A Miller; Francis D Pagani; Donna M Mancini Journal: JAMA Cardiol Date: 2020-06-01 Impact factor: 14.676
Authors: David Snipelisky; John M Stulak; Sarah D Schettle; Shashank Sharma; Sudhir S Kushwaha; Shannon M Dunlay Journal: Am Heart J Date: 2015-08-16 Impact factor: 4.749
Authors: Sigrid E Sandner; Daniel Zimpfer; Philipp Zrunek; Angela Rajek; Heinrich Schima; Daniela Dunkler; Andreas O Zuckermann; Georg M Wieselthaler Journal: J Heart Lung Transplant Date: 2009-04 Impact factor: 10.247
Authors: Mustafa M Ahmed; Stephen M Magar; Eric I Jeng; George J Arnaoutakis; Thomas M Beaver; Juan Vilaro; Charles T Klodell; Juan M Aranda Journal: Clin Cardiol Date: 2018-11-20 Impact factor: 2.882
Authors: Khansa Ahmad; Edward W Chen; Umair Nazir; William Cotts; Ambar Andrade; Amal N Trivedi; Sebhat Erqou; Wen-Chih Wu Journal: J Am Heart Assoc Date: 2019-09-04 Impact factor: 5.501